Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy.
Maschio
M
M
Dinapoli
L
L
Vidiri
A
A
Muti
Paola
P
D000927:Anticonvulsants / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy*; D002220:Carbamazepine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000009:adverse effects*; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy* / Q000209:etiology; D005076:Exanthema / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000078330:Oxcarbazepine; D011878:Radiotherapy / Q000009:adverse effects; D000077204:Temozolomide
D000927:Anticonvulsants; D000970:Antineoplastic Agents; D002220:Carbamazepine; D003606:Dacarbazine; D000078330:Oxcarbazepine; D000077204:Temozolomide